Abstract pollen tube growth, leaf bending and epinasty, root inhibition, induction of ethylene biosynthesis, protonRecent studies on dwarf mutants of Arabidopsis, pump activation, xylem differentiation, and regulation of tomato and pea have provided convincing evidence gene expression (Mandava, 1988; Clouse and Sasse, that brassinosteroids are a unique class of plant hor-1998). In addition, useful agricultural applications have mones that are essential for normal plant growth.
Introduction the cotyledons expand and new leaves develop, accompanied by the induction of many genes involved in photoSteroid hormones are crucial for embryonic development synthetic function, while the hypocotyl, whose elongation and adult homeostasis in animals (Evans, 1988) .
is dramatically inhibited, becomes thicker and acts as a Similarly, the insect steroid hormone, ecdysone, triggers physical support to hold newly developed leaves. Such a a key regulatory cascade of gene expression controlling developmental switch from one suited to an underground many developmental processes such as moulting, environment to one suited to full sunlight is often referred metamorphosis and reproduction ( Thummel, 1995) . In to as photomorphogenesis, or de-etiolation (Cosgrove, plants, many steroids have been identified, but only one 1986). class of steroids, called collectively brassinosteroids, have
In order to understand the molecular mechanisms wide distribution throughout the plant kingdom and regulating this process, a genetic screen was initiated to unique growth-promoting activity when applied exogenidentify Arabidopsis mutants that display many characterously (Mandava, 1988; Fujioka and Sakurai, 1997) .
istics of light-grown plants when grown in the dark Physiological studies done in several laboratories have (Chory et al., 1989) . So far, mutants of over 18 loci have demonstrated that brassinosteroids can induce a broad spectrum of cellular responses such as stem elongation, been isolated and characterized ( Wei and Deng, 1996) .
Among these mutants are recessive alleles of a gene ments with various brassinosteroids suggest that they act at the C-23 and C-22 hydroxylation steps, respectively, called DET2. Loss of-function mutations in DET2 have pleiotropic effects on Arabidopsis development (Chory in the biosynthetic pathway ( Fig. 1 ; Szekeres et al., 1996; Choe et al., 1998a) . Both CBB3 ( Kauschmann et al., et al., 1991) . In the dark, det2 mutants are short, have thick hypocotyls, accumulate anthocyanins, have open, 1996) and DWF3 (Choe et al., 1998b) are allelic to CPD. The Arabidopsis DWF1/DIM1/CBB1 protein ( Feldmann expanded cotyledons, develop primary leaf buds, and inappropriately express light-regulated genes. In the light, et al., 1989; Takahashi et al., 1995; has strong homology with several unknown det2 mutants are dark-green dwarfs, have reduced apical dominance and male fertility, display altered photoproteins of pea, human, and C. elegans (J. Li and J. Chory, unpublished data) , and is suggested to be an periodic responses, show delayed chloroplast and leaf senescence, and respond improperly to fluctuations in FAD-dependent oxidoreductase (Mushegian and Koonin, 1995) . Quantitative analysis of endogenous brassinostheir light environment. Such phenotypic differences between det2 mutants and wild-type Arabidopsis plants teroid levels in dim1 mutants suggests that the dim1 mutation might block the conversion of indicate that DET2 plays an important role throughout Arabidopsis development.
24-methylenecholesterol to campesterol (Fig. 1; Clouse and Sasse, 1998) . Mutations in each of these genes result in phenotypes that are very similar to those of det2
Brassinosteroid biosynthesis mutants and these mutants can also be rescued by brassinosteroid treatment. Given the fact that mutations in DET2 encodes a protein that exhibits significant sequence identity with mammalian steroid 5a-reductases that are each of these genes affect many aspects of light-regulated Arabidopsis development, the recent molecular genetic involved in animal steroid metabolism (Li et al., 1996) . In addition, a conservative substitution of a glutamate analyses of these dwarf mutants have provided convincing evidence that brassinosteroids are a unique class of plant (Glu204), which is absolutely conserved among all mammalian steroid 5a-reductases and is essential for the hormones that are essential for normal plant growth and development. activity of a type 2 human 5a-reductase (Russell and Wilson, 1994) , completely abolishes the in vivo activity
The identification of additional brassinosteroiddeficient dwarf mutants in both Arabidopsis and other of DET2 protein, strongly suggesting that DET2 might be involved in the biosynthesis of plant steroids such as plant species further confirms the importance of these steroids in plant development. Three novel Arabidopsis brassinosteroids. Consistent with this hypothesis, brassinosteroid treatment rescued the growth defects of both dwarf mutants including dwf5, dwf7 and dwf8 were recently found to be defective in brassinosteroid biodark and light-grown det2 mutants (Li et al., 1996; Fujioka et al., 1997) . When expressed in mammalian synthesis (Choe et al., 1998b) . Results from feeding experiments and analyses of endogenous brassinosteroid cells, DET2 protein was able to 5a-reduce several animal steroids including testosterone and progesterone. levels have indicated that both dwf5 and dwf7 mutants are defective in the formation of 24-methylenecholesterol, Moreover, the expression of human genes encoding steroid 5a-reductases complemented a det2 mutation, a precursor to campesterol, while the dwf8 mutation is suggested to block a late step after 3-dehydroteasterone demonstrating that DET2 is a functional homologue of mammalian steroid 5a-reductases . det2 in the brassinolide biosynthetic pathway ( Fig. 1 ; Choe et al., 1998b) . The lkb mutant of pea is a brassinosteroidmutants accumulated only 8-15% of the wild-type level of campestanol and less than 10% of the wild-type levels deficient dwarf that shows normalization of internode elongation upon application of a range of brassinosteroids of other brassinosteroids and failed to convert 2H-labelled campesterol to 2H-labelled campestanol, showing that and a recent study suggested that the lkb mutation, like the Arabidopsis dim1 mutation, det2 is a brassinosteroid-deficient mutant. A further proof came from rescue experiments in which all intermediates blocks the conversion of 24-methylenecholesterol to campesterol ( Fig. 1 ; Clouse and Sasse, 1998) . Another pea of the brassinosteroid biosynthetic pathway after the DET2 reaction were capable of rescuing det2 mutant mutant, lk, is believed to be defective in the conversion of campesterol to campestanol and the corresponding phenotypes. Taken together, these results establish that DET2 is a brassinosteroid biosynthetic enzyme catalysing gene LK might encode a pea homologue of the Arabidopsis DET2 ( Fig. 1 ; Yokota et al., 1997) . The DWARF gene of an early step in the brassinosteroid biosynthetic pathway ( Fig. 1 ; Fujioka et al., 1997) .
tomato was recently cloned by transposon tagging and shown to encode a cytochrome P450 with 38% sequence In addition to the DET2 gene, there are several putative brassinosteroid biosynthetic genes that have been cloned identity to the Arabidopsis CPD (Bishop et al., 1996) . Preliminary feeding experiments suggest that the tomato recently in Arabidopsis. Both CPD and DWF4 encode cytochrome P450 proteins that share sequence similarities DWARF is also a brassinosteroid biosynthetic enzyme, acting later in the biosynthetic pathway than CPD (Clouse with mammalian steroid hydroxylases and feeding experi- The early C-6 oxidation pathway is on the left side and the late C-6 oxidation pathway is on the right side. Steps of phytosterol biosynthesis leading to the formation of campesterol are included and known mutations that block either biosynthesis of or response to brassinosteroids are indicated ( X ). Question marks indicate uncertainty about exact biochemical lesions and the broken arrows denote mutilple steps. This diagram is adopted from Clouse and Sasse (1998) and Choe et al. (1998a). and Sasse, 1998). Another tomato mutant, dpy, was developmental signals. Feeding experiments using det2 and dwf4 mutants have consistently shown that brassinosfound to be deficient in C-23 hydroxylation of both cathasterone and 6-deoxocathasterone, implying that teroids in the late C-6 oxidation pathway are more effective in rescuing light phenotypes whereas the brassi-DPY is the tomato homologue of CPD (Fig. 1; Clouse and Sasse, 1998) .
nosteroids in the early C-6 oxidation pathways show stronger activity in promoting hypocotyl elongation of The brassinosteroid-deficient mutants and the cloned brassinosteroid-biosynthetic genes provide an important dark-grown seedlings (Fujioka et al., 1997; Choe et al., 1998a) . Further measurements of endogenous brassinostool for investigating not only the physiological functions but also the biosynthetic pathways of brassinosteroids.
teroid intermediates of different subpathways and detailed analysis of expression patterns of key brassinosteroid The detailed metabolic analyses of det2 mutants coupled with the biochemical characterization of DET2 protein biosynthetic genes under different environmental conditions or at different developmental stages should help to aided the identification of a 3-oxo, D4-5 steroid, 3-dehydro-D4-5-campesterol, as a direct substrate of the understand the regulation of brassinosteroid biosynthesis. Metabolic studies with wild-type Arabidopsis and det2 DET2 reductase ( Fig. 1 ; Li et al., 1997; Fujioka et al., 1997) . Such a study also concluded that Arabidopsis seedlings indicate that the reaction catalysed by DET2 is a major rate-limiting step in the brassinosteroid biosynmust have a plant orthologue of the mammalian 3b-hydroxysteroid dehydrogenase/D5-6-D4-5 isothetic pathway (S Fujioka, personal communication) . Consistent with such an observation, overexpression of merases to catalyse the conversion of campesterol to 3-dehydro-D4-5-campesterol and the conversion of DET2 in Arabidopsis results in transgenic plants that are significantly larger than wild-type plants in the light, while 3-dehydrocampestanol to campestanol (Fig. 1) . Indeed, recent database searches indicate that the Arabidopsis underexpression of DET2 using an antisense DET2 construct leads to an allelic series of plants ranging from genome contains at least two genes for such an enzyme (J Li and J Chory, unpublished results). Quantitative det2-like dwarfs to wildtype in stature . These results support the early claims that brassianalysis of campestanol levels in three presumed null alleles of det2 has suggested that there is a second steroid nosteroid applications could increase crop productivity. Likewise, the 22-hydroxylation reaction has also been 5a-reductase in Arabidopsis that plays a minor role in brassinosteroid biosynthesis ( Fujioka et al., 1997) , which hypothesized to be a rate-limiting step (Fujioka et al., 1995) . Therefore, DWF4 might be another limiting activmight explain the relatively weak phenotypes of det2 mutants compared to cpd/cbb3/dwf3 mutants. Further ity in the biosynthesis of brassinolide (Choe et al., 1998a) . Biochemical, metabolic and transgenic studies are needed molecular and genetic studies should aid in the identification of this second reductase and the elucidation of its to confirm whether DWF4 does catalyse a rate-limiting reaction in the brassinosteroid biosynthetic pathway. If physiological function during plant development.
The existence of various brassinosteroid-deficient mutso, it will be interesting to see whether overexpression of both DET2 and DWF4 genes will have a great effect on ants allowed the testing of the possibility that brassinolide is not synthesized via a simple linear biosynthetic paththe biomass of transgenic plants. Analysing the expression of the cloned brassinosteroid way. Recently, two pathways, the so-called early C-6 oxidation and late C-6 oxidation pathways, were proposed biosynthetic genes can provide hints to where brassinosteroids are synthesized and how brassinosteroid biofor the biosynthesis of brassinolide ( Fig. 1; Fujioka and Sakurai, 1997) . Feeding experiments with intermediates synthesis is regulated. DET2 appears to be constitutively and ubiquitously expressed throughout Arabidopsis develof both pathways provided strong genetic evidence that both pathways are operating in Arabidopsis (Fujioka opment and in response to different light conditions D Friedrichsen and J Chory, unpubet al., 1997; Choe et al., 1998a) . A recent study with dwf4 mutants suggests that 22-hydroxyl-campesterol might be lished observations). In contrast, the expression of CPD is confined to cotyledon and leaf primordia in dark-grown a starting point for a new subpathway since this compound is able to rescue dwf4 mutations (Choe et al., seedlings and the adaxial parenchyma of expanding leaves in light-grown plants. CPD expression is not detected in 1998a). Similarly, 6a-hydroxycampesterol could also be a starting point for a different subpathway whose intereither actively elongating cells of hypocotyls and roots, or pollen and seeds where the highest brassinolide levels mediates act as 'bridging molecules' between the early and late C-6 oxidation pathways (Choe et al., 1998a) .
have been detected (Mathur et al., 1998) . Such an expression pattern of CPD might suggest that brassinosteroids Identification of new brassinosteroid biosynthetic intermediates in vivo are needed to confirm whether these are synthesized in both cotyledons and leaves and are then transported to the organs that require high levels of hypothesized subpathways exist in plants. One simple explanation for plants having multiple pathways of brassibrassinosteroids for normal growth. Alternatively, there might be enzymatic machineries that reduce the levels of nosteroid biosynthesis is that these subpathways might be differentially regulated by various environmental or active brassinosteroids to relieve a feedback inhibition on CPD expression in either cotyledons or expanding leaves. Surprisingly, brassinosteroid regulates BRU1 expression at a post-transcriptional rather than a transcriptional Several different enzyme reactions have been implicated in brassinosteroid inactivation such as hydroxylation, level . A brassinosteroidregulated XET has also been identified in Arabidopsis glycosylation, acylation, and side-chain degradation (Fujioka and Sakurai, 1997; Adam et al., 1996) . Both ( Xu et al., 1995) . The TCH4 gene encodes an XET whose expression is increased within 30 min of brassinosteroid the transport and metabolism of 14C-labelled 24-epibrassinolide have been studied in cucumber and treatment, with a maximum at 2 h. In addition to brassinosteroids, this gene is also regulated by touch, darkness, wheat seedlings ( Fujioka and Sakurai, 1997) . When applied to roots, 24-epibrassinolide is readily taken up temperature shock and auxin. In contrast to soybean BRU1, the brassinosteroid-regulated TCH4 expression and transported to leaves; in contrast, when applied to leaves, its transport is quite slow. It was later shown that occurs at the transcriptional level ( Xu et al., 1995) . The brassinosteroid-responsive element has been mapped to a this compound is quickly metabolized in leaves, but not in hypocotyls and roots. As such, these results are 100 bp fragment of the TCH4 promoter (Clouse and Sasse, 1998) and linker-scanning mutagenesis is underway consistent with the second hypothesis.
to identify the specific brassinosteroid response element(s) for this gene.
Brassinosteroid signal transduction
A recent study has shown that expression of CPD is specifically down-regulated by brassinolide although its Having established the essential role of brassinosteroids in plant growth and development, the most interesting transcription is not affected by other plant hormones including auxin, ethylene, gibberellin, cytokinin, jasmonic question to ask is how plants recognize these steroids and transduce their signals to regulate a wide spectrum of acid, and salicylic acid (Mathur et al., 1998) . Such a brassinosteroid-induced repression of CPD transcription developmental processes. To understand the molecular mechanism by which brassinosteroids regulate plant is sensitive to the protein synthesis inhibitor cycloheximide, indicating a requirement for de novo synthesis development, it is necessary to identify components of the brassinosteroid response pathway, including recepof a negative transcriptional regulator (Mathur et al., 1998) . Mapping of brassinosteroid-response element(s) in tor(s), intermediates, and targets. Currently, both molecular and genetic approaches have been taken to investigate the CPD promoter is necessary to find transcriptional factors regulating CPD gene expression. the molecular mechanisms of brassinosteroid signalling.
The molecular approach is to clone brassinosteroidThe genetic approach to the identification of components of the brassinosteroid signalling pathway is the regulated genes, understand their functions, map their corresponding brassinosteroid-responsive cis-acting eleisolation and characterization of Arabidopsis mutants deficient in brassinosteroid responses. Screens for ments and identify trans-acting regulatory factors mediating brassinosteroid-regulated gene expression. It has been hormone-insensitive mutants in Arabidopsis have proven to be fruitful in the study of plant hormone action. As demonstrated that brassinosteroid-induced responses require de novo protein synthesis (Mandava, 1988) and examples, screens for mutants that are insensitive to high levels of exogenously applied auxins, ethylene, gibberelbrassinosteroid-treatment induces synthesis of both mRNAs and proteins (Clouse, 1996) . Using a differential lins, and abscisic acid have led to the identification of loci involved in signalling from these plant hormones. hybridization method, a brassinosteroid up-regulated (BRU1) gene was identified from elongating soybean Among the ethylene-insensitive loci are ETR1 and ETR2, which encode ethylene receptors (Chang et al., 1993; epicotyls (Zurek and Clouse, 1994) . BRU1 encodes a protein that showed significant homology to various Sakai et al., 1998 ). An Arabidopsis brassinosteroid-insensitive mutant xyloglucan endotransglycosylases ( XETs) which have been implicated in cell wall loosening during cell (bri1) was originally identified by a root-growth inhibition assay (Clouse et al., 1996) . bri1 seedlings display similar elongation (Clouse, 1996) . A later study proved that BRU1 is indeed a functional XET (Oh et al., 1998) . The pleiotropic phenotypes to brassinosteroid-deficient mutants, yet can not be rescued by brassinosteroid treatexpression level of BRU1 correlates with the extent of brassinosteroid-promoted stem elongation and the accument. The bri1 mutants showed marked insensitivity only to brassinosteroids but retain complete sensitivities to mulation of the BRU1 transcript parallels the brassinosteroid-mediated increases in plastic extensibility of the auxins, cytokinins, gibberellins, abscisic acid, and ethylene. A second brassinosteroid insensitive mutant cell wall . Moreover, a linear relationship has been observed cbb2, has been isolated independently in a genetic screen for cabbage-like Arabidopsis mutants ( Kauschmann et al. , between brassinosteroid concentrations and extractable XET activities in brassinosteroid treated soybean epi-1996) and was later found to be allelic to bri1. Brassinosteroid insensitivity in the cbb2 mutant has also cotyls (Oh et al, 1998) , strongly suggesting an involvement of BRU1 in brassinosteroid-stimulated stem elongation. been observed at the molecular level. The brassinosteroid-induced expression of two XET genes, TCH4 and meri5, that regulate gene expression (Beato et al., 1995) ; however, cell surface steroid receptors are known to be present is missing in the mutant, although GA-induced meri5 expression is still observed . A in animal cells mediating non-genomic effects of steroid hormones (McEwen, 1991) and protein tyrosine phosdifferent genetic screen, designed specifically for brassinosteroid-response mutants with brassinosteroid-deficient phorylation has been implicated in such a membraneinitiated steroid signalling pathway (Tesarik et al., 1993 ; phenotypes, has also been performed. The screen involved two steps: a primary screen for det2 or cpd-like dwarf Mendoza et al., 1995) . Second, while many LRR-containing proteins are mutants followed by a secondary screen for dwarfism that could not be rescued by brassinosteroid treatment.
involved in signal transduction pathways, LRRs are believed to mediate protein-protein interactions and, in This screen yielded 18 bin (brassinosteroid insensitive) mutants that were later found to be new alleles of the many cases, provide binding sites for protein ligands ( Kobe and Deisenhofer, 1994) . So far, no LRR has ever BRI1/CBB2 locus. Recently, three dwf2 alleles were found to be allelic to bri1 (Clouse and Sasse, 1998) and two been found to interact with small compounds. Interestingly enough, the predicted BRI1 protein contains new bri1 alleles were identified from a collection of dwarf mutants at the Arabidopsis Biological Resource Center a unique 70 amino-acid island buried between the 21st and 22nd LRRs. The importance of this island in BRI1's ( The Ohio State University, Ohio, USA) and a private collection of T-DNA insertion lines (J. Li and J. Chory, function is self-evident by sequencing two bri1 alleles, both of which have a missense mutation in this domain unpublished data), thus bringing the total number of bri1 alleles to 25. It is somewhat surprising that all brassinos- J. Li and J. Chory, unpublished results) . In contrast, of 19 bri1 alleles that have been teroid-insensitive mutants isolated in four different genetic screens are all alleles of a single gene. This suggests that sequenced, no allele contains a mutation in the LRRs themselves. It is worthwhile to note that mutations in BRI1 is the only unique and specific component in the brassinosteroid signalling pathway and other components LRRs have been identified in both erecta and clv1 alleles ( Torri et al., 1996; Clark et al., 1997) . Careful biochemical of the pathway are either redundant (mutants would have no obvious phenotype) or shared with other signalling studies are needed to determine whether BRI1 is a brassinosteroid receptor, and if so, whether the island is cascades (mutants would be lethal ). Brassinosteroidinsensitive mutants have also been identified in both pea directly involved in binding brassinosteroids. BRI1's kinase domain must be essential for the BRI1's (lka, and tomato (cu-3, Clouse and Sasse, 1998) ( Fig. 1). function. Of the 19 bri1 alleles sequenced to date, 15 have mutations in this domain ; J. Li and The almost identical phenotypes between bri1 and cpd, the most severe brassinosteroid-deficient mutant isolated J. Chory, unpublished results) . This domain must interact with other downstream signalling components to transto date, strongly suggests that BRI1 encodes an early component of the brassinosteroid response pathway, most duce the steroid signal. One protein that might interact with BRI1's kinase domain is a type 2C phosphatase likely a brassinosteroid receptor. Recently, the Arabidopsis BRI1 gene was cloned by chromosome walking (Li and ( KAPP) which has been implicated to be involved in both RLK5 and CLV1-mediated signalling pathways and found to encode a protein that has significant sequence identity to a family of plant leucine- (Stone et al., 1994; Williams et al., 1997) . Indeed, a fusion protein between glutathione S-transferase (GST ) and rich-repeat (LRR) receptor-like kinases including Xa21 of rice (Song et al., 1995) , ERECTA and CLV1 of BRI1's kinase domain interacts with this phosphatase in vitro (J. Li and J. Chory, unpublished results) . Transgenic Arabidopsis ( Torii et al., 1996; Clark et al., 1997) . The predicted BRI1 protein contains several distinct domains: experiments are underway to find the physiological relevance of such an interaction. a signal peptide, a putative leucine-zipper motif, 25 leucine-rich-repeats, a 70 amino-acid island buried between the 21st and 22nd LRR, and a cytoplasmic
Conclusion and perspectives
kinase domain that has serine/threnine kinase activity when expressed in E. coli or animal cells (J Li, C To understand completely how brassinosteroids act in plants, more components of the brassinosteroid response Joazeiro and J Chory, unpublished data).
The finding that BRI1 is a LRR-containing receptor pathways need to be isolated and characterized. It might be possible to identify proteins involved in brassinosteroid kinase is quite a surprise. First, while a transmembrane receptor kinase is a central theme in many signal transducsignal transduction that directly interact with BRI1's kinase domain by a yeast two-hybrid screening or intertion events ( Ullrich and Schlessinger, 1990) , no such receptor kinase has ever been found to be involved in a active cloning strategy. Although four different genetic screenings have resulted in the identification of only one steroid signal transduction pathway. All known steroid receptors belong to a superfamily of nuclear receptor brassinosteroid signalling component, BRI1, at least two other genetic screens can be used to identify new componproteins that are ligand-dependent transcription factors
